Circulation, Vol 81, 1606-1621, Copyright © 1990 by American Heart Association
DS Goldstein, PC Chang, G Eisenhofer, R Miletich, R Finn, J Bacher, KL Kirk, S Bacharach and IJ Kopin
Sites of uptake, storage, and metabolism of [18F]fluorodopamine and
excretion of [18F]fluorodopamine and its metabolites were visualized using
positron emission tomographic (PET) scanning after intravenous injection of
the tracer into anesthetized dogs. Radioactivity was concentrated in the
renal pelvis, heart, liver, spleen, salivary glands, and gall bladder.
Uptake of 18F by the heart resulted in striking delineation of the left
ventricular myocardium. Pretreatment with desipramine markedly decreased
cardiac positron emission, consistent with dependence of the heart on
neuronal uptake (uptake-1) for removal of circulating catecholamines. In
reserpinized animals, cardiac positron emission was absent within 30
minutes after injection of [18F]-6-fluorodopamine, demonstrating that the
emission in untreated animals was from radioactive labeling of the
sympathetic storage vesicles. Decreased positron emission from denervated
salivary glands confirmed that the tracer was concentrated in sympathetic
neurons. Radioactivity in the gall bladder and urinary system depicted the
hepatic and renal excretion of the tracer and its metabolites.
Administration of tyramine or nitroprusside increased and ganglionic
blockade with trimethaphan decreased the rate of loss of myocardial
radioactivity. The results show that PET scanning after administration of
[18F]fluorodopamine can be used to visualize sites of sympathetic
innervation, follow the metabolism and renal and hepatic excretion of
catecholamines, and examine cardiac sympathetic function.
ARTICLES
Positron emission tomographic imaging of cardiac sympathetic innervation and function
Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
This article has been cited by other articles:
![]() |
M. Hadi, C. C. Chen, M. Whatley, K. Pacak, and J. A. Carrasquillo Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma J. Nucl. Med., July 1, 2007; 48(7): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Tipre and D. S. Goldstein Cardiac and Extracardiac Sympathetic Denervation in Parkinson's Disease with Orthostatic Hypotension and in Pure Autonomic Failure J. Nucl. Med., November 1, 2005; 46(11): 1775 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, S.-T. Li, C. Holmes, and K. Bankiewicz Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson's Disease J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gourgiotis, N. J. Sarlis, J. C. Reynolds, C. VanWaes, M. J. Merino, and K. Pacak Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 637 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1867 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, C. Holmes, R. O. Cannon, G. Eisenhofer, and I. J. Kopin Sympathetic Cardioneuropathy in Dysautonomias N. Engl. J. Med., March 6, 1997; 336(10): 696 - 702. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |